Ftse Mib
39.069,40
1,07%
DAX
23.147,02
2,90%
S&P 500
5.849,72
-1,76%
NASDAQ
18.350,19
-2,64%
Bitcoin
83.982,89
-2,44%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Castle Biosciences Inc (CSTL) Castle Biosciences Inc (CSTL) Notizie

Castle Biosciences Inc

CSTL
21,27
-0,41 (-1,89%)
04 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/2/202522:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202522:07EDGAR2Form 8-K - Current report
27/2/202522:05BWCastle Biosciences Reports Fourth Quarter and Full-Year 2024..
25/2/202522:30BWCastle Biosciences to Participate in Upcoming Investor..
24/2/202522:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202522:30BWCastle Biosciences to Share Data Reinforcing the Clinical..
06/2/202513:00BWCastle Biosciences to Release Fourth Quarter and Full-Year..
17/1/202513:00BWCastle’s Poster on DecisionDx®-SCC Selected as a “Late..
13/1/202500:00BWCastle Biosciences Announces Preliminary Unaudited Fourth..
09/1/202500:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:29EDGAR2Form 144 - Report of proposed sale of securities
06/1/202513:00BWCastle Biosciences Announces New York State Department of..
23/12/202413:00BWCastle Biosciences Highlights Progress for its Pipeline..
19/12/202413:00BWCastle Biosciences Reports Inducement Grants Under Nasdaq..
12/12/202413:00BWIndependent Systematic Review and Meta-Analysis Attests to..
11/12/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202413:00BWCastle Biosciences to Present at the Piper Sandler 36th..
19/11/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202413:00BWCastle Biosciences Earns a Houston Chronicle Top Workplaces..
14/11/202419:39EDGAR2Form 144 - Report of proposed sale of securities
08/11/202413:00BWCastle Biosciences to Present New Data Highlighting the..
07/11/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202413:00BWCastle Biosciences Surpasses 25,000 Test Reports Delivered..
06/11/202413:00BWUse of Castle Biosciences’ DecisionDx®-Melanoma Test..
05/11/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202422:07EDGAR2Form 8-K - Current report
04/11/202422:05BWCastle Biosciences Reports Third Quarter 2024 Results
01/11/202421:49EDGAR2Form 144 - Report of proposed sale of securities
29/10/202421:30BWCastle Biosciences Presents Award-Winning Abstract at ACG..
28/10/202412:00BWCastle Biosciences to Participate in Upcoming Investor..
20/10/202411:00BWCastle Biosciences Presents New Data at ASDS from..
16/10/202413:00BWRecent Publications Affirm the Value of Gene Expression..
14/10/202413:00BWCastle Biosciences to Release Third Quarter 2024 Financial..
11/10/202413:00BWCastle Biosciences to Support the 71st Annual Montagna..
09/10/202413:00BWNew Prospective, Multicenter Study Presented at SMR..
02/10/202413:00BWCastle Biosciences Hosts Groundbreaking Ceremony at Site of..
27/9/202423:15BWNew Data at ASTRO 2024 Shows Castle Biosciences’..
23/9/202413:00BWNew Data at AFS 2024 Demonstrates the Strength of Castle..
16/9/202413:00BWCastle Biosciences’ Chief Operating Officer Kristen..
11/9/202413:00BWDecisionDx®-Melanoma Can Identify Melanoma Patients with Low..
05/9/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202413:00BWStudy Confirms the Ability of Castle Biosciences'..
28/8/202413:00BWCastle Biosciences to Participate in Upcoming Investor..
14/8/202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 21,76 Min: 21,165 Max: 22,39
Chiusura: 21,68

La tua Cronologia

NASDAQ
CSTL
Castle Biosciences
BOV
PHMO34M
PhilipMorris
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci